本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Evelo Biosciences

0.0005
+0.0000
成交量:9.00
成交额:0.00
市值:9,491.42
市盈率:0.00
高:0.0005
开:0.0005
低:0.0005
收:0.0005
数据加载中...
2024/01/27

重要事件披露

Form 8-K - Current report
2024/01/26

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/26

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/12/27

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/12/04

重要事件披露

Form 8-K - Current report
2023/11/21

重要事件披露

Form 8-K - Current report
2023/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/28

重要事件披露

Form 8-K - Current report
2023/10/17

重要事件披露

Form 8-K - Current report
2023/08/21

重要事件披露

Form 8-K - Current report
2023/08/15

SEC问询函

Form CORRESP - Correspondence
2023/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/14

重要事件披露

Form 8-K - Current report
2023/07/22

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/07/21

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/07/20

重要事件披露

Form 8-K - Current report
2023/07/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/07/12

重要事件披露

Form 8-K - Current report
2023/07/10

重要事件披露

Form 8-K - Current report
2023/07/08

重要事件披露

Form 8-K - Current report